Source link : https://www.newshealth.biz/health-news/fda-oks-next-gen-cologuard-test-for-crc-screening/
The US Food and Drug Administration (FDA) approved Exact Sciences’ next-generation multitarget stool DNA (mt-sDNA) test, Cologuard Plus, for use in adults 45 or older who are at average risk for colorectal cancer (CRC). Developed in collaboration with Mayo Clinic, the company notes in the news release announcing its approval that this noninvasive test “raises […]
Author : News Health
Publish date : 2024-10-04 19:16:20
Copyright for syndicated content belongs to the linked Source.
Categories